Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma

Taura,Naota; Ichikawa,Tatsuki; Miyaaki,Hisamitsu; Yatsuhashi,Hiroshi; Ishibashi,Hiromi; Nakao,Kazuhiko

doi:10.3892/etm.2010.167

Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma

Authors:
- Naota Taura
- Tatsuki Ichikawa
- Hisamitsu Miyaaki
- Hiroshi Yatsuhashi
- Hiromi Ishibashi
- Kazuhiko Nakao
View Affiliations

Affiliations: Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan, Clinical Research Center, National Hospital Organization, Nagasaki Medical Center and Department of Hepatology, Graduate School of Biomedical Sciences Nagasaki University, Nagasaki 856-8562, Japan
Published online on: December 2, 2010 https://doi.org/10.3892/etm.2010.167
Pages: 81-84

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The possibility has been raised in a number of cohort and case-control studies that diabetes mellitus (DM) may increase the risk of liver cancer, as well as that of cancer at other sites. To verify this possibility, we conducted a retrospective cohort study to determine the prevalence of type 2 DM in Japanese patients with hepatocellular carcinoma (HCC). A total of 1,251 patients with HCC, diagnosed at two major liver centers in the Nagasaki area, were consecutively recruited and categorized according to the etiology of HCC into four groups: HCC-B, HCC-C, HCC-BC and HCC-nonBC cases. Type 2 DM was diagnosed on the basis of standard criteria. The prevalence rate of HCC-nonBC and HCC-C was significantly higher than that of HCC-B, while the prevalence rate of HCC-nonBC was significantly higher than that of HCC-C. The prevalence of type 2 DM in HCC-B, HCC-C and HCC-nonBC patients under 66 years of age was 11, 31 and 32%, respectively, vs. 24, 22 and 40%, respectively, in patients over 66 years of age. In patients over 66 years of age, the prevalence of type 2 DM in HCC-B and HCC-nonBC cases was increased, whereas the prevalence of type 2 DM in HCC-C cases was significantly decreased. Our findings indicate that the effects of the interaction between type 2 DM and HCV increase the prevalence of HCC.

View Figures

View References

1.	Kiyosawa K and Tanaka E: Characteristics of hepatocellular carcinoma in Japan. Oncology. 62:5–7. 2002. View Article : Google Scholar
2.	Umemura T and Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res. 37(Suppl 2): 95–100. 2007. View Article : Google Scholar
3.	El-Serag HB: Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 35:S72–S78. 2002. View Article : Google Scholar : PubMed/NCBI
4.	Taura N, Yatsuhashi H, Nakao K, Ichikawa T and Ishibashi H: Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan. Oncol Rep. 21:223–227. 2009.PubMed/NCBI
5.	Moore MA, Park CB and Tsuda H: Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev. 7:89–107. 1998.PubMed/NCBI
6.	El-Serag HB and Everhart JE: Diabetes increases the risk of acute hepatic failure. Gastroenterology. 122:1822–1828. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Ajiki W, Tsukuma H and Oshima A: Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol. 34:352–356. 2004. View Article : Google Scholar : PubMed/NCBI
8.	Shintani Y, Fujie H, Miyoshi H, et al: Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 126:840–848. 2004. View Article : Google Scholar : PubMed/NCBI
9.	Polesel J, Zucchetto A, Montella M, et al: The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol. 20:353–357. 2009. View Article : Google Scholar : PubMed/NCBI
10.	El-Serag HB, Tran T and Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 126:460–468. 2004. View Article : Google Scholar : PubMed/NCBI
11.	Davila JA, Morgan RO, Shaib Y, McGlynn KA and El-Serag HB: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 54:533–539. 2005. View Article : Google Scholar : PubMed/NCBI
12.	Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M and Tsugane S: Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 166:1871–1877. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Fujino Y, Mizoue T, Tokui N and Yoshimura T: Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev. 17:374–379. 2001. View Article : Google Scholar : PubMed/NCBI
14.	Wideroff L, Gridley G, Mellemkjaer L, et al: Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 89:1360–1365. 1997. View Article : Google Scholar : PubMed/NCBI
15.	Ichikawa T, Yanagi K, Motoyoshi Y, et al: Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis. J Gastroenterol Hepatol. 21:1865–1866. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Adami HO, Chow WH, Nyren O, et al: Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 88:1472–1477. 1996. View Article : Google Scholar : PubMed/NCBI
17.	Le Roith D: Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med. 336:633–640. 1997.PubMed/NCBI
18.	Stuver SO, Kuper H, Tzonou A, et al: Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int J Cancer. 87:118–121. 2000. View Article : Google Scholar : PubMed/NCBI
19.	Su TS, Liu WY, Han SH, et al: Transcripts of the insulin-like growth factors I and II in human hepatoma. Cancer Res. 49:1773–1777. 1989.PubMed/NCBI
20.	Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer. 65:311–320. 1992. View Article : Google Scholar : PubMed/NCBI
21.	Nakano T and Ito H: Epidemiology of diabetes mellitus in old age in Japan. Diabetes Res Clin Pract. 77(Suppl 1): 76–81. 2007. View Article : Google Scholar
22.	Davila JA, Morgan RO, Shaib Y, McGlynn KA and El-Serag HB: Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 127:1372–1380. 2004. View Article : Google Scholar : PubMed/NCBI
23.	Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE and Kral JG: Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord. 19:846–850. 1995.PubMed/NCBI
24.	Czaja AJ, Carpenter HA, Santrach PJ and Moore SB: Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol. 29:198–206. 1998. View Article : Google Scholar : PubMed/NCBI
25.	Fraser GM, Harman I, Meller N, Niv Y and Porath A: Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci. 32:526–530. 1996.PubMed/NCBI
26.	Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC and Lu SN: Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol. 45:636–645. 2010. View Article : Google Scholar
27.	Lai MS, Hsieh MS, Chiu YH and Chen TH: Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 43:1295–1302. 2006. View Article : Google Scholar : PubMed/NCBI
28.	Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D and Adami HO: Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst. 92:1096–1099. 2000. View Article : Google Scholar : PubMed/NCBI